English
Español

(805) 483 1185

Participate in a study!

Linkedin-in Instagram Facebook-f
01 Fomat_Logo_Website-min
proud-partner-HCI-V6
  • Home
  • About Us
    • About Us
    • Our Site Network
  • Our Solutions
  • Our Capabilities
    • eClinical Trials
    • NASH Capabilities
    • COVID Solutions
    • Vaccine Capabilities
  • For Sites
  • News & Updates
  • Contact FOMAT
  • More
    • Patient Home Page
    • Fomat Latam: Inicio

Home » Blogs & Updates » Page 2

Posts in category: Blogs & Updates

Novavax

Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program

July 7, 2020
by marketing_fomat

With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg, ...

Read More
0
pharma lab-covid 19

Want to reopen your pharma lab amid COVID-19? Consider these strategies first

July 7, 2020
by marketing_fomat

COVID-19 has unleashed a logistical conundrum for pharma lab leaders: How do you keep momentum in therapeutics development, when, like all workplaces, most labs have had to either restrict use or close altogether? The answer lies, at least in part, i ...

Read More
1
covid-19-vaccine

Milken Institute Teams with First Person to Explain the Race to a COVID-19 Vaccine

June 15, 2020
by marketing_fomat

WASHINGTON--(BUSINESS WIRE)-- The Milken Institute, the nonprofit, nonpartisan think tank, and First Person, a San Francisco design and storytelling company, together tell the urgent story of the global race for a COVID-19 vaccine in a newly released ...

Read More
0
Covid-19 Virus Cell Images Photo

2 Million COVID-19 Cases | ‘Uniquely Worse Than I Can Remember’

June 15, 2020
by marketing_fomat

With the U.S. surpassing 2 million cases of COVID-19, infectious disease experts have learned a tremendous amount about SARS-CoV-2's transmissibility, the effects of infection, and how (or how not) to treat it. David Aronoff, MD, of Vanderbilt Uni ...

Read More
0
FDA

FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron

June 9, 2020
by marketing_fomat

The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period. Viela Bio’s Inebilizumab for NMOSD Gaithersburg, Maryland-based Viela Bio has a target action date of June 11 for its Bi ...

Read More
0
covid

Biopharma Update on the Novel Coronavirus: June 8

June 9, 2020
by marketing_fomat

FDA Actions Reissued EUAs: The FDA reissued EUAs revising which types of respirators can be decontaminated for reuse. Availability and Capability of Non-Invasive Monitoring Devices: The FDA issued new guidance that expands the availability and capabi ...

Read More
0
nebulizer

Respira Technologies Seeks Drug Candidates for its Nebulizer

June 9, 2020
by marketing_fomat

Respira Technologies (West Hollywood, Calif.) announced the launch of a pharmaceutical-focused commercial development program for its RespiRx drug-delivery device platform. RespiRx is a portable, handheld vibrating mesh nebulizer designed for local a ...

Read More
0
covid-vaccine

Merck, IAVI Work to Develop COVID-19 Vaccine

June 5, 2020
by marketing_fomat

Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technolog ...

Read More
0
Covid Treatment | Image of Vaccine and Needles

Phlow Lands $354M Government Contract for COVID-19 Medications

June 1, 2020
by marketing_fomat

Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response. Richmond, Va.-based Phlow’s manufacturing is being f ...

Read More
0
covid 19

Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year

April 16, 2020
by fomat_medical

Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. Janssen and the virology lab led by Dr. Dan Ba ...

Read More
0
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • ...
  • 42
  • Next
  • Last

Recent Posts

  • We are hiring a Project Manager! 
  • National Endometriosis Awareness Month
  • Rare Disease Day
  • American Heart Month
  • National Blood Donor Month: “Donating is giving life”

Categories

  • Blogs & Updates
  • Company Updates
  • eClinical Trials Category
  • Social Media
  • Uncategorized
  • Whitepapers

Upcoming Events

Digestive Disease Week

May 21-24

San Diego, CA 

Bio Convention

June 13 - 16th

San Diego, CA

 

 

Contact Us

FOMAT Medical Research INC,
300 South A Street Suite 201 Oxnard, CA 93030
(805) 483 1185
Trial Information: [email protected]
General Information: [email protected]
  • Review us on Google
  • Review us on Yelp

Site Map | Privacy Policy

Shopping Basket